companydata.dkcompanydata.dk

AJ Vaccines A/S: Financial statements 2019

CVR: 37911143

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 323,471,000 and a net result of DKK -288,603,000 compared with DKK -244,490,000 the year before. That is a decrease of 10.7% compared with the year before. The profit margin was -89.2%. Equity in the 2019 report amounted to DKK 1,185,744,000. The solvency ratio was 64.1%. The company had 719 employees in the financial year.

Revenue
DKK 323,471,000
Gross Profit
DKK -224,533,000
Profit/Loss
DKK -288,603,000
Equity
DKK 1,185,744,000
Total Assets
DKK 1,850,926,000
Employees
719

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019323.5M-224.5M-288.6M1.2B719
2018362.2M-150.7M-244.5M903.2M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Jerome Christian Roger Cabannes joins AJ Vaccines A/S as directorJul 31, 2019

As of July 31, 2019, Jerome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.

Jérome Christian Roger Cabannes joins AJ Vaccines A/S as directorJul 31, 2019

As of July 31, 2019, Jérome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.

AJ Vaccines A/S: The 2018 annual report is outJun 3, 2019

AJ Vaccines A/S has published its annual report for 2018. Revenue came to DKK 362,192,000, and the net result was DKK -244,490,000.

About AJ Vaccines A/S

AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.

Source: annual report 2025, Danish Business Authority

Other financial years